ArticleMolecular pharmaceutics2025

Targeted Oral Fixed-Dose Combination of Amphotericin B-Miltefosine for Visceral Leishmaniasis.

Raquel Fernández-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.